Increased arterial stiffness in Systemic Lupus Erythematosus (SLE) patients at low risk for cardiovascular disease: A cross-sectional controlled study

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Sacre, Karim ^a,b,c   Escoubet, Brigitte ^a   Pasquet, Blandine ^a   Chauveheid, Marie Paule ^a   Zennaro, Maria Christina ^d   Tubach, Florence ^a   Papo, Thomas ^a,b,c  

^a BICHAT HOSPITAL   (France)

^b CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^c Dept Hospitalo Univ FIRE ^*  (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PREDNISONE; STEROID;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR DISEASE; CAROTID ARTERY PULSE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; HYPERTENSION; INTERNAL CAROTID ARTERY; LOW RISK PATIENT; MALE; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; ARTERIAL WALL THICKNESS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAROTID ARTERY; CASE CONTROL STUDY; COMPLICATION; FEMORAL ARTERY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PULSE WAVE; STATISTICAL MODEL;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FEMORAL ARTERY; GLUCOCORTICOIDS; HUMANS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84899563286     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094511     Document Type: Article

References (32)

1. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, et al. (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis and Rheumatism 44: 2331-2337. (Pubitemid 32977500)
2. Aranow C, Ginzler EM (2000) Epidemiology of cardiovascular disease in systemic lupus erythematosus. Lupus 9: 166-169. (Pubitemid 30199257)
3. Bjornadal L, Yin L, Granath F, Klareskog L, Ekbom A (2004) Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95. The Journal of Rheumatology 31: 713-719. (Pubitemid 38451257)
4. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, et al. (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. American Journal of Epidemiology 145: 408-415. (Pubitemid 27084212)
5. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, et al. (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. The New England Journal of Medicine 349: 2399-2406. (Pubitemid 37542988)
6. Ward MM (1999) Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis and Rheumatism 42: 338-346.
7. Svenungsson E, Jensen-Urstad K, Heimburger M, Silveira A, Hamsten A, et al. (2001) Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 104: 1887-1893. (Pubitemid 32983229)
8. Doria A, Shoenfeld Y, Wu R, Gambari PF, Puato M, et al. (2003) Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases 62: 1071-1077. (Pubitemid 37323571)
9. Goldberg RJ, Urowitz MB, Ibanez D, Nikpour M, Gladman DD (2009) Risk factors for development of coronary artery disease in women with systemic lupus erythematosus. The Journal of Rheumatology 36: 2454-2461.
10. Kullo IJ, Malik AR (2007) Arterial ultrasonography and tonometry as adjuncts to cardiovascular risk stratification. Journal of the American College of Cardiology 49: 1413-1426. (Pubitemid 46482924)
11. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, et al. (2010) 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 56: e50-103.
12. Cacciapaglia F, Zardi EM, Coppolino G, Buzzulini F, Margiotta D, et al. (2009) Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients. Lupus 18: 249-256.
13. Chin CW, Tan RS, Thumboo J (2012) Endothelial function and arterial stiffness assessment as early surrogate markers of vascular risk in patients with systemic lupus erythematosus. Clinical and Experimental Rheumatology 31: 295-301.
14. Selzer F, Sutton-Tyrrell K, Fitzgerald S, Tracy R, Kuller L, et al. (2001) Vascular stiffness in women with systemic lupus erythematosus. Hypertension 37: 1075-1082. (Pubitemid 32304007)
15. Roman MJ, Devereux RB, Schwartz JE, Lockshin MD, Paget SA, et al. (2005) Arterial stiffness in chronic inflammatory diseases. Hypertension 46: 194-199. (Pubitemid 40946513)
16. Sabio JM, Vargas-Hitos J, Zamora-Pasadas M, Mediavilla JD, Navarrete N, et al. (2009) Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus. The Journal of Rheumatology 36: 2204-2211.
17. Valero-Gonzalez S, Castejon R, Jimenez-Ortiz C, Rosado S, Tutor-Ureta P, et al. (2013) Increased arterial stiffness is independently associated with metabolic syndrome and damage index in systemic lupus erythematosus patients. Scandinavian Journal of Rheumatology. DOI: 10.3109/03009742.2013.803150
18. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 40: 1725.
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA: The Journal of the American Medical Association 285: 2486-2497.
20. (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 28: 1039-1057.
21. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis and Rheumatism 35: 630-640.
22. Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, et al. (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Annals of Internal Medicine 142: 953-962.
23. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, et al. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis: JTH 4: 295-306.
24. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, et al. (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99: 2434-2439. (Pubitemid 29218240)
25. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, et al. (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Journal of the American Society of Nephrology: JASN 15: 241-250. (Pubitemid 38140764)
26. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, et al. (1995) Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 26: 485-490.
27. Taquet A, Bonithon-Kopp C, Simon A, Levenson J, Scarabin Y, et al. (1993) Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. European Journal of Epidemiology 9: 298-306. (Pubitemid 23238057)
28. Rahman P, Aguero S, Gladman DD, Hallett D, Urowitz MB (2000) Vascular events in hypertensive patients with systemic lupus erythematosus. Lupus 9: 672-675. (Pubitemid 32011792)
29. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, et al. (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Annals of the Rheumatic Diseases 69: 325-331.
30. Karp I, Abrahamowicz M, Fortin PR, Pilote L, Neville C, et al. (2008) Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Arthritis and Rheumatism 59: 169-175. (Pubitemid 351272950)
31. Ruyssen-Witrand A, Fautrel B, Saraux A, Le Loet X, Pham T (2011) Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review. Joint, Bone, Spine: revue du rhumatisme 78: 23-30.
32. Parker B, Urowitz MB, Gladman DD, Lunt M, Bae SC, et al. (2013) Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Annals of the Rheumatic Diseases 72: 1308-1314.